Assertion: implantable electronic device | /r/HasProperty | reprogrammed
Facets:
Source sentences:
text: The literature is insufficient to evaluate the benefits of: (1) continuing to monitor and display a patient’s electrocardiogram; (2) monitoring cardiac rate and rhythm throughout the immediate postoperative period; (3) ensuring that back-up pacing and cardioversion–defibrillation equipment are immediately available; and (4) restoring the cardiac implantable electronic device to its permanent setting before the patient is discharged from a monitored environment when the cardiac implantable electronic device has been reprogrammed pre- or intraoperatively.
text: B4-B evidence).The literature is insufficient to evaluate the benefits of: (1) continuing to monitor and display a patient’s electrocardiogram; (2) monitoring cardiac rate and rhythm throughout the immediate postoperative period; (3) ensuring that back-up pacing and cardioversion–defibrillation equipment are immediately available; and (4) restoring the cardiac implantable electronic device to its permanent setting before the patient is discharged from a monitored environment when the cardiac implantable electronic device has been reprogrammed pre- or intraoperatively.
text: The consultants and ASA members strongly agree with the following recommendations: (1) continuously monitor cardiac rate and rhythm throughout the immediate postoperative period; (2) for a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively, ensure that back-up pacing and cardioversion–defibrillation equipment is immediately available until the permanent settings are restored; (3) for a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively, restore the cardiac implantable electronic device to its permanent settings before the patient is discharged from a monitored environment; (4) if interrogation determines that the cardiac implantable electronic device settings are inappropriate, then reprogram the cardiac implantable electronic device to newly appropriate settings; (5) perform a postoperative cardiac implantable electronic device interrogation if emergency surgery occurred without appropriate preoperative cardiac implantable electronic device evaluation; (6) perform a postoperative cardiac implantable electronic device interrogation if there is suspicion that antitachycardia therapy might have been disabled rather than temporarily suspended with magnet placement; (7) perform a postoperative cardiac implantable electronic device interrogation if significant electromagnetic interference occurred in close proximity to the cardiac implantable electronic device; and (8) perform a postoperative cardiac implantable electronic device interrogation if the delivery of antitachycardia therapy was observed or if there is concern for cardiac implantable electronic device malfunction.
text: The consultants and ASA members strongly agree with the following recommendations: (1) continuously monitor cardiac rate and rhythm throughout the immediate postoperative period; (2) for a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively, ensure that back-up pacing and cardioversion–defibrillation equipment is immediately available until the permanent settings are restored; (3) for a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively, restore the cardiac implantable electronic device to its permanent settings before the patient is discharged from a monitored environment; (4) if interrogation determines that the cardiac implantable electronic device settings are inappropriate, then reprogram the cardiac implantable electronic device to newly appropriate settings; (5) perform a postoperative cardiac implantable electronic device interrogation if emergency surgery occurred without appropriate preoperative cardiac implantable electronic device evaluation; (6) perform a postoperative cardiac implantable electronic device interrogation if there is suspicion that antitachycardia therapy might have been disabled rather than temporarily suspended with magnet placement; (7) perform a postoperative cardiac implantable electronic device interrogation if significant electromagnetic interference occurred in close proximity to the cardiac implantable electronic device; and (8) perform a postoperative cardiac implantable electronic device interrogation if the delivery of antitachycardia therapy was observed or if there is concern for cardiac implantable electronic device malfunction.
text: For a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively: Ensure that back-up pacing and cardioversion–defibrillation equipment are immediately available until the cardiac implantable electronic device’s permanent settings are restored ‖‖‖‖23 Ensure that the patient’s cardiac rate and rhythm are continuously monitored and displayed until the cardiac implantable electronic device’s permanent settings are restored ####24 Ensure that the patient remains in a monitored environment until
text: For a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively: Ensure that back-up pacing and cardioversion–defibrillation equipment are immediately available until the cardiac implantable electronic device’s permanent settings are restored §§§§§§§§45 Ensure the patient’s cardiac rate and rhythm are continuously monitored and displayed until the cardiac implantable electronic device’s permanent settings are restored ‖‖‖‖‖‖‖‖46
text: The percentage of responding consultants expecting no change associated with each linkage were as follows: preoperative evaluation (determining whether a patient has a cardiac implantable electronic device and that it is functioning properly), 83.3%; patient preparation (determining whether electromagnetic interference is likely to occur), 83.3%; consulting a specialist when needed to alter the pacing function of a cardiac implantable electronic device, 75.0%; having temporary pacing and defibrillation equipment immediately available before, during, and after procedures with electromagnetic interference potential, 91.7%; continuous monitoring of electrocardiography, Sp o 2 , and peripheral pulse, 91.7%; electrosurgery, 100%; radiofrequency ablation, 100%; lithotripsy, 91.7%; magnetic resonance imaging, 91.7%; radiation therapy, 100%; radiofrequency identification devices, 100%; electroconvulsive therapy, 100%; emergency defibrillation or cardioversion, 91.7%; postoperative management (continuing to monitor and display electrocardiogram, cardiac rate, and rhythm), 100%; postoperative management (for a cardiac implantable electronic device that was reprogrammed pre- or intraoperatively, restore the cardiac implantable electronic device to its permanent settings before the patient is discharged from a monitored environment), 83.3%; and postoperative cardiac implantable electronic device interrogation, 91.7%.